Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis

18 September 2019 - In this study, the investigators examined the characteristics of randomised controlled trials that supported approval of cancer ...

Read more →

Why Canada can't be America's pharmacy

11 September 2019 - Canada doesn't have enough drugs to share, and it doesn't want that role. ...

Read more →

New rules will keep the best medications from desperate Canadians

12 September 2019 - One reaction to recent amendments to the rules of the federal Patented Medicine Prices Review Board, ...

Read more →

Big Pharma is abusing patents, and it's hurting Americans

12 September 2019 - The American patent system has, since our nation's founding, served as a cornerstone of innovation. But ...

Read more →

Ardelyx receives FDA approval for Ibsrela (tenapanor), an NHE3 sodium transport inhibitor, for the treatment of irritable bowel syndrome with constipation

12 September 2019 - Approval supported by two Phase 3 trials demonstrating a statistically significant reduction in constipation and abdominal pain ...

Read more →

Nucala is the first biologic approved in the US for six to 11-year-old children with severe eosinophilic asthma

12 September 2019 - GlaxoSmithKline today announced that the US FDA has approved Nucala (mepolizumab) for use in children as young ...

Read more →

Aspen's drug to prevent preterm birth approved by FDA

13 September 2019 - The U.S. Food and Drug Administration (FDA) has approved Aspen Pharmacare’s hydroxyprogesterone caproate, which is used to ...

Read more →

ICER publishes evidence report on additive cardiovascular disease therapies

12 September 2019 - Pricing of rivaroxaban and icosapent ethyl aligns well with treatments’ benefits for patients; expert roundtable will discuss ...

Read more →

SMC U-turn for Vertex’s CF drugs

12 September 2019 - Vertex has announced that following a change of heart by the SMC, eligible cystic fibrosis patients ...

Read more →

Be grateful for your health insurance company

11 September 2019 - It has the thankless job of saying ‘no.’ But policing claims allows you to get better benefits. ...

Read more →

Kiwi cancer survival rates improving at slower rate than comparable countries, study shows

12 September 2019 - New Zealand is near the bottom for cancer survival compared to six other countries with similar ...

Read more →

When are RCTs required for breakthrough drugs, HDEs? JAMA study investigates

11 September 2019 - A new study in JAMA Network Open finds that drugs and medical devices approved by the ...

Read more →

NICE publishes its 600th technology appraisal guidance

12 September 2019 - The guidance relates to the use of pembrolizumab in combination with carboplatin and paclitaxel on the ...

Read more →

Immunotherapy a groundbreaking new cancer treatment, but prohibitively expensive

10 September 2019 - Dave Roberts is fighting for his life, and his doctor says there is only one option ...

Read more →

We need to make biosimilars easier to get

11 September 2019 - If potential biosimilar manufacturers can’t get their product to market, they won’t proceed with development. ...

Read more →

Children with rare inherited condition to benefit from drug through managed access agreement

11 September 2019 - It is estimated that in the UK there are around 30 to 50 children living with the ...

Read more →